Tags

Type your tag names separated by a space and hit enter

[Medicinal cannabis].

Abstract

Medicinal cannabis The use of cannabis products for medical purposes is rapidly increasing in the Netherlands. Studies suggest that these products have positive effects in the treatment of chronic neuropathic pain, multiple-sclerosis-related spasticity, certain epilepsy syndromes and chemotherapy-related nausea and vomiting. The interpretation of these findings is impeded by methodological shortcomings, such as a small number of participants. Differences in product composition and dosage form mean that study resultsare often not directly comparable. Responsible prescribing requires that the patient be very well informed about the goal of treatment, alternative forms of treatment and the side effects. A history of psychosis, relevant cardiac co-morbidity, recurrent falls, addiction problems, pregnancy and breastfeeding are all contra-indications to the use of medical cannabis.

Authors+Show Affiliations

Propersona, afd. Ouderenpsychiatrie, Arnhem. Contact: G.A.H. van den Elsen (g.van.den.elsen@propersona.nl).Canisius-Wilhelmina Ziekenhuis, afd. Interne Geneeskunde, Nijmegen.Radboudumc, afd. Chirurgie, Nijmegen.Radboudumc, afd. Klinische Geriatrie, Nijmegen.Radboudumc, afd. Farmacologie en Toxicologie, Nijmegen.Radboudumc, afd. Psychiatrie, Nijmegen.

Pub Type(s)

English Abstract
Journal Article

Language

dut

PubMed ID

31120212

Citation

van den Elsen, Geke A H., et al. "[Medicinal Cannabis]." Nederlands Tijdschrift Voor Geneeskunde, vol. 163, 2019.
van den Elsen GAH, In 't Hout FEM, de Vries M, et al. [Medicinal cannabis]. Ned Tijdschr Geneeskd. 2019;163.
van den Elsen, G. A. H., In 't Hout, F. E. M., de Vries, M., Olde Rikkert, M. G. M., Kramers, C., & Verkes, R. J. (2019). [Medicinal cannabis]. Nederlands Tijdschrift Voor Geneeskunde, 163.
van den Elsen GAH, et al. [Medicinal Cannabis]. Ned Tijdschr Geneeskd. 2019 May 3;163 PubMed PMID: 31120212.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Medicinal cannabis]. AU - van den Elsen,Geke A H, AU - In 't Hout,Florentien E M, AU - de Vries,Marjan, AU - Olde Rikkert,Marcel G M, AU - Kramers,C, AU - Verkes,Robbert-Jan, Y1 - 2019/05/03/ PY - 2019/5/24/entrez JF - Nederlands tijdschrift voor geneeskunde JO - Ned Tijdschr Geneeskd VL - 163 N2 - Medicinal cannabis The use of cannabis products for medical purposes is rapidly increasing in the Netherlands. Studies suggest that these products have positive effects in the treatment of chronic neuropathic pain, multiple-sclerosis-related spasticity, certain epilepsy syndromes and chemotherapy-related nausea and vomiting. The interpretation of these findings is impeded by methodological shortcomings, such as a small number of participants. Differences in product composition and dosage form mean that study resultsare often not directly comparable. Responsible prescribing requires that the patient be very well informed about the goal of treatment, alternative forms of treatment and the side effects. A history of psychosis, relevant cardiac co-morbidity, recurrent falls, addiction problems, pregnancy and breastfeeding are all contra-indications to the use of medical cannabis. SN - 1876-8784 UR - https://www.unboundmedicine.com/medline/citation/31120212/[Medicinal_cannabis] DB - PRIME DP - Unbound Medicine ER -